Aug. 24, 2020 Price forecast | 2 weeks: 5.96% | 1 month: 5.69% | 3 months: 2.06%


CNSP stock forecast

Our latest prediction for CNS Pharmaceuticals, Inc.'s stock price was made on the Aug. 24, 2020 when the stock price was at 2.16$.

In the short term (2weeks), CNSP's stock price should outperform the market by 5.96%. During that period the price should oscillate between -10.96% and +23.55%.

In the medium term (3months), CNSP's stock price should outperform the market by 2.06%. During that period the price should oscillate between -43.68% and +48.14%.

Create a solid portfolio with CNSP

Add CNSP to your portfolio and optimize it!


About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.50$ per share.

The book value per share is 0.23$

CNS Pharmaceuticals, Inc. website


Three months stock forecastAug. 24, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -8M - -8M -0.50 - - 15M 0.23 -7M - -7M